Brazil Approves U.S. Cannabis Product RSHO as Imported Medication to Treat Cancer

Medical Marijuana, Inc. has announced to its shareholders and the public that the Brazilian government has approved its hemp-derived cannabidiol (CBD) oil product, Real Scientific Hemp Oil™ (RSHO™), to be imported as a prescription medication for cancer, and is subsidizing its cost under the Brazilian federal government’s heath care system.

“We have the utmost respect for the Brazilian government that decided hemp CBD oil should be available to their people, for a variety of reasons. Medical Marijuana, Inc. is actively working with other governments to also make hemp CBD products available. We look forward to more progress on a global scale in the very near future,” states Stuart W. Titus, Ph.D. and Chief Executive Officer of Medical Marijuana, Inc.

Cancer is among the leading causes of death worldwide, with 14 million new cases and 8.2 million deaths recorded in 2014 alone according to data from the National Institutes...

e-mail icon Facebook icon Twitter icon LinkedIn icon Reddit icon
Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.